| Ms Sharon Debora Squibb, CNM | |
|
330 Laurel St Ste 2300, Des Moines, IA 50314 | |
| (515) 643-6869 | |
| (515) 643-6899 |
| Full Name | Ms Sharon Debora Squibb |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 28 Years |
| Location | 330 Laurel St Ste 2300, Des Moines, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467524306 | NPI | - | NPPES |
| 7633 | Other | IA | ACNM CERTIFICATION NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | CNM-78A (Idaho) | Secondary |
| 367A00000X | Advanced Practice Midwife | B-119773 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lucas County Health Center | Chariton, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lucas County Health Center | 8921916792 | 26 |
News Archive
President Obama plans to address Congress on Wednesday, only a day after lawmakers return from their August break, to spell out in detail his vision for overhauling health care, The Associated Press reports. The move signals that "Democrats have all but given up hope for a bipartisan breakthrough by Senate Finance Committee negotiators," because that committee - the only one seeking across-the-aisle compromise - had been given a Sept. 15 deadline.
Proton therapy, an external beam radiotherapy in which protons deliver precise radiation doses to a tumor and spare healthy organs and tissues, is cost-effective in treating medulloblastomas, fast-growing brain tumors that mainly affect children, when compared to standard photon radiation therapy, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting.
Bruker today announces the launch of the new INVENIO™ Fourier Transform Infrared (FT-IR) research spectrometer. The INVENIO is the successor to the renowned VERTEX 70 FT-IR for advanced R&D applications.
Topline results from the European LipiDiDiet clinical trial were presented today as part of a late-breaking presentation at the Advances in Alzheimer's Therapy congress.
The U.S. Food and Drug Administration (FDA) has announced the launch of an orphan drug workshop series-an opportunity for biotechnology companies, pharmaceutical firms, academics and other interested parties to spend two days creating applications for orphan status designation, under the guidance of staff from FDA's Office of Orphan Products Development (OOPD).
› Verified 8 days ago
| Entity Name | Lucas County Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588636351 PECOS PAC ID: 8921916792 Enrollment ID: O20040317001356 |
News Archive
President Obama plans to address Congress on Wednesday, only a day after lawmakers return from their August break, to spell out in detail his vision for overhauling health care, The Associated Press reports. The move signals that "Democrats have all but given up hope for a bipartisan breakthrough by Senate Finance Committee negotiators," because that committee - the only one seeking across-the-aisle compromise - had been given a Sept. 15 deadline.
Proton therapy, an external beam radiotherapy in which protons deliver precise radiation doses to a tumor and spare healthy organs and tissues, is cost-effective in treating medulloblastomas, fast-growing brain tumors that mainly affect children, when compared to standard photon radiation therapy, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting.
Bruker today announces the launch of the new INVENIO™ Fourier Transform Infrared (FT-IR) research spectrometer. The INVENIO is the successor to the renowned VERTEX 70 FT-IR for advanced R&D applications.
Topline results from the European LipiDiDiet clinical trial were presented today as part of a late-breaking presentation at the Advances in Alzheimer's Therapy congress.
The U.S. Food and Drug Administration (FDA) has announced the launch of an orphan drug workshop series-an opportunity for biotechnology companies, pharmaceutical firms, academics and other interested parties to spend two days creating applications for orphan status designation, under the guidance of staff from FDA's Office of Orphan Products Development (OOPD).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Sharon Debora Squibb, CNM Po Box 1475, Des Moines, IA 50305-1475 Ph: (515) 643-6869 | Ms Sharon Debora Squibb, CNM 330 Laurel St Ste 2300, Des Moines, IA 50314 Ph: (515) 643-6869 |
News Archive
President Obama plans to address Congress on Wednesday, only a day after lawmakers return from their August break, to spell out in detail his vision for overhauling health care, The Associated Press reports. The move signals that "Democrats have all but given up hope for a bipartisan breakthrough by Senate Finance Committee negotiators," because that committee - the only one seeking across-the-aisle compromise - had been given a Sept. 15 deadline.
Proton therapy, an external beam radiotherapy in which protons deliver precise radiation doses to a tumor and spare healthy organs and tissues, is cost-effective in treating medulloblastomas, fast-growing brain tumors that mainly affect children, when compared to standard photon radiation therapy, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting.
Bruker today announces the launch of the new INVENIO™ Fourier Transform Infrared (FT-IR) research spectrometer. The INVENIO is the successor to the renowned VERTEX 70 FT-IR for advanced R&D applications.
Topline results from the European LipiDiDiet clinical trial were presented today as part of a late-breaking presentation at the Advances in Alzheimer's Therapy congress.
The U.S. Food and Drug Administration (FDA) has announced the launch of an orphan drug workshop series-an opportunity for biotechnology companies, pharmaceutical firms, academics and other interested parties to spend two days creating applications for orphan status designation, under the guidance of staff from FDA's Office of Orphan Products Development (OOPD).
› Verified 8 days ago
Ms. Dana Lynne Ericson, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 1250 39th St, Des Moines, IA 50311 Phone: 515-279-3320 Fax: 515-279-9619 | |
Ms. Cynthia Anne Hyde, ARNP CNM MPH Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 2679 Maury St, Des Moines, IA 50317 Phone: 515-244-6162 Fax: 515-266-3105 | |
Sarah M. Schoen, CNM, IBCLC Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 3509 E 29th St, Des Moines, IA 50317 Phone: 515-248-1600 Fax: 515-248-1610 | |
Dr. Sarah Bradbury, C.N.M. Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1801 Hickman Rd, Des Moines, IA 50314 Phone: 155-282-2340 Fax: 515-282-7860 | |
Katie Elizabeth Bowling, Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 3509 E 29th St, Des Moines, IA 50317 Phone: 515-248-1600 | |
Rebecca Jean Schleuger-valadao, A.R.N.P. Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 733 19th St, Des Moines, IA 50314 Phone: 515-266-6712 | |
Pamela J Jach, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 330 Laurel St Ste 2300, Des Moines, IA 50314 Phone: 515-643-6869 Fax: 515-643-6899 |